VICTORIA, April 4 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV - News; TSX: ASV - News) today announced that Bruce Cousins, EVP and CFO, will be presenting at the CIBC World Markets Biotechnology and Specialty Pharmaceuticals Conference in New York.

The 25 minute presentation will be followed by a 25 minute question and answer session. Mr. Cousins' presentation will take place on Thursday, April 12th at 1:20 pm ET at the Millennium Broadway Hotel.

A live audio web cast of the presentation will be available to all interested parties through a link posted on Aspreva's website at http://www.zjjv.com/ in the Investors section.

About Aspreva Pharmaceuticals

Aspreva is an emerging pharmaceutical company focused on identifying, developing and, upon regulatory approval, commercializing new indications for approved drugs and late stage drug candidates for patients living with less common diseases. Aspreva is listed on the NASDAQ Global Select Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV".

CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com

Source: Aspreva Pharmaceuticals